EGM
IMVT icon

Engineers Gate Manager’s Immunovant IMVT Stock Holding History

Engineers Gate Manager’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$933K Buy
24,220
+15,560
+180% +$474K 0.01% 1134
2026
Q1 		$215K Buy
+8,660
New +$224K ﹤0.01% 1877
2025
Q2 		– Sell
-26,720
Closed -$457K – 2336
2025
Q1 		$457K Sell
26,720
-9,017
-25% -$189K 0.01% 1495
2024
Q4 		$885K Buy
+35,737
New +$1.01M 0.02% 1087
2024
Q3 		– Sell
-13,564
Closed -$358K – 2238
2024
Q2 		$358K Buy
+13,564
New +$386K 0.01% 1374
2024
Q1 		– Sell
-8,451
Closed -$356K – 2089
2023
Q4 		$356K Buy
+8,451
New +$311K 0.01% 1355
2023
Q3 		– Sell
-26,519
Closed -$503K – 1932
2023
Q2 		$503K Buy
+26,519
New +$495K 0.02% 1031
2022
Q2 		– Sell
-14,300
Closed -$79K – 2061
2022
Q1 		$79K Buy
14,300
+567
+4% +$3.53K ﹤0.01% 1735
2021
Q4 		$117K Buy
+13,733
New +$113K 0.01% 1786

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Engineers Gate Manager's IMVT Position: Q2 2026 in Review

Engineers Gate Manager increased its Immunovant (IMVT) stake by 180% in Q2 2026, buying an estimated $474K and bringing the position to 24,220 shares worth $933K. The position accounts for 0.01% of the portfolio, ranked #1134.

Engineers Gate Manager first reported a position in IMVT in Q4 2021 and has held it in 9 quarters since. 227 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Engineers Gate Manager held 24,220 shares of Immunovant worth $933K as of Q2 2026.
  • Engineers Gate Manager bought 15,560 Immunovant shares in Q2 2026, an estimated $474K.
  • Immunovant made up 0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #1134 holding.
  • Engineers Gate Manager first reported a position in Immunovant in Q4 2021 and has held it in 9 quarters since.
  • 227 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.